Internal Medicine, Endocrinology, Diabetes, & Metabolism · Jackson, MS
NPI
1780899922
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
971 Lakeland Dr, St. Dominic West Tower Suite 450
Jackson, MS, 39216
Phone (601) 948-5158
Groups this clinician bills Medicare through
Medicare paid, 2024
$247K
11,125 services
Medicare patients, 2024
818
Average age 74
Drug cost, 2024
$3.1M
11,656 prescriptions
Company payments, 2025
$2,345
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Raymond F Grenfell III was code 99214 (office e&m - established), 1,426 times for 788 patients. In total Raymond F Grenfell III billed 11,125 services in 50 codes, and Medicare paid $247K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-05-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,426 | 788 | $78.62 | $112K |
| 36415 Venipuncture Blood Collection | Office | 1,382 | 758 | $8.59 | $12K |
| 83036 Blood Count | Office | 1,016 | 500 | $9.48 | $9,633 |
| 80053 Clinical Chemistry | Office | 1,000 | 498 | $10.30 | $10K |
| 80061 Clinical Chemistry | Office | 987 | 487 | $13.06 | $13K |
| 83721 Clinical Chemistry | Office | 987 | 487 | $10.25 | $10K |
| 84439 Clinical Chemistry | Office | 976 | 646 | $8.80 | $8,587 |
| 84443 Clinical Chemistry | Office | 973 | 646 | $16.38 | $16K |
| 95251 Test - Miscellaneous | Office | 343 | 145 | $24.09 | $8,264 |
| 82306 Clinical Chemistry | Office | 321 | 247 | $28.67 | $9,204 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 247 | 232 | $11.42 | $2,821 |
| 82043 Clinical Chemistry | Office | 231 | 225 | $5.66 | $1,307 |
| 82570 Clinical Chemistry | Office | 231 | 225 | $5.08 | $1,173 |
| 82607 Clinical Chemistry | Office | 179 | 148 | $14.60 | $2,613 |
| 80048 Clinical Chemistry | Office | 176 | 116 | $8.21 | $1,444 |
By year: 2022 $231K for 10,855 services; 2023 $232K for 10,573 services; 2024 $247K for 11,125 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,382 | 758 | $8.59 | $12K |
| 83036 Blood Count | 1,016 | 500 | $9.48 | $9,633 |
| 80053 Clinical Chemistry | 1,000 | 498 | $10.30 | $10K |
| 80061 Clinical Chemistry | 987 | 487 | $13.06 | $13K |
| 83721 Clinical Chemistry | 987 | 487 | $10.25 | $10K |
| 84439 Clinical Chemistry | 976 | 646 | $8.80 | $8,587 |
| 84443 Clinical Chemistry | 973 | 646 | $16.38 | $16K |
| 82306 Clinical Chemistry | 321 | 247 | $28.67 | $9,204 |
| 82570 Clinical Chemistry | 231 | 225 | $5.08 | $1,173 |
| 82043 Clinical Chemistry | 231 | 225 | $5.66 | $1,307 |
Medicare prescription drug claims, 2024
In 2024, the drug Raymond F Grenfell III prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 1,343 prescriptions and refills. In total Raymond F Grenfell III wrote 11,656 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 1,343 | 2,493 | 251 | $105K |
| Levothyroxine Sodium Generic | 828 | 2,010 | 205 | $7,210 |
| Atorvastatin Calcium Generic | 506 | 1,416 | 138 | $4,399 |
| Jardiance Empagliflozin | 472 | 665 | 83 | $374K |
| Ozempic Semaglutide | 450 | 576 | 79 | $528K |
| Glimepiride Generic | 406 | 1,065 | 109 | $3,179 |
| Metformin Hcl Generic | 381 | 1,021 | 110 | $2,714 |
| Rosuvastatin Calcium Generic | 336 | 894 | 94 | $2,898 |
| Pravastatin Sodium Generic | 311 | 827 | 83 | $3,672 |
| Januvia Sitagliptin Phosphate | 252 | 375 | 45 | $193K |
| Tresiba Flextouch U-100 Insulin Degludec | 250 | 501 | 60 | $153K |
| Metformin Hcl Er Metformin Hcl | 231 | 640 | 68 | $2,642 |
| Amlodipine Besylate Generic | 197 | 531 | 56 | $1,047 |
| Farxiga Dapagliflozin Propanediol | 197 | 267 | 31 | $145K |
| Lisinopril Generic | 192 | 526 | 55 | $1,180 |
Brand drugs: 5,510 claims; generic drugs: 5,727 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Raymond F Grenfell III $2,345 ($2,345 in general payments such as food, travel and fees) from 26 companies. The largest payer was Corcept Therapeutics with $304.
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics CORT | 12 | $304 |
| Dexcom, Inc. DXCM | 16 | $264 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $209 |
| Abbott Laboratories ABT | 10 | $182 |
| Lilly USA, LLC LLY | 12 | $178 |
| Beta Bionics, Inc. BBNX | 9 | $145 |
| Amgen Inc. AMGN | 11 | $140 |
| Novo Nordisk Inc NVO | 3 | $125 |
| Sequel Med Tech, LLC | 5 | $96.64 |
| Medtronic, Inc. MDT | 3 | $92.84 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.